Anmeldung erfolgt in Kürze...
Details werden geladen...
expert reaction to a target trial emulation study on risk of hair loss associated with GLP-1 RAs in adults with type 2 diabetes | Science Media Centre
Ähnliche Seiten
expert reaction to a multi-target trial emulation study looking at GLP- 1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder | Science Media Centre
https://www.sciencemediacentre.org/expert-reaction-to-a-multi-target-trial-emulation-study-looking-at-glp-1-receptor-agonists-and-alcohol-related-hospitalisations-among-adults-with-alcohol-use-disorder/expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes | Science Media Centre
https://www.sciencemediacentre.org/expert-reaction-to-two-studies-looking-at-astrazenecas-glp-1-pill-elecoglipron-for-reducing-weight-and-lowering-blood-sugar-in-adults-with-and-without-type-2-diabetes/expert reaction to study on risk of formaldehyde and benzene exposure from a sealed stationary recreational vehicle | Science Media Centre
https://www.sciencemediacentre.org/expert-reaction-to-study-on-risk-of-formaldehyde-and-benzene-exposure-from-a-sealed-stationary-recreational-vehicle/expert reaction to study looking at prolonged sedentary behaviour and cancer risk | Science Media Centre
https://www.sciencemediacentre.org/expert-reaction-to-study-looking-at-prolonged-sedentary-behaviour-and-cancer-risk/expert reaction to announcement (not published study) of topline results from the TRIUMPH-1 Phase 3 clinical trial of Retatrutide | Science Media Centre
https://www.sciencemediacentre.org/expert-reaction-to-announcement-not-published-study-of-topline-results-from-the-triumph-1-phase-3-clinical-trial-of-retatrutide/